लोड हो रहा है...
Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature
INTRODUCTION: Pimavanserin (Nuplazid™) is an atypical antipsychotic currently indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis. The antipsychotic effects of this new agent are believed to occur via selective inverse agonist activity at serotonin...
में बचाया:
| में प्रकाशित: | Ment Health Clin |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007714/ https://ncbi.nlm.nih.gov/pubmed/29955528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.09.230 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|